SUMMARY Certain strains of Escherichia coli producing verotoxin have been isolated in the stools of patients with the haemolytic uraemic syndrome. A platelet aggregating activity has been found in normal plasma after incubation with verotoxin at 37°C for 24 h. This activity, unlike neuraminidase, has an effect that is independent of changing factor VIII related antigen, but requires the IIA and IIIB platelet surface glycoprotein (deficient in thrombasthenia) to mediate its effect. Prostacyclin totally inhibited this effect, but other antiplatelet drugs and heparin were without inhibitory effects.
The haemolytic uraemic syndrome is characterised by microangiopathic haemolytic anaemia, thrombocytopenia, and renal failure,' usually preceded by a prodromal period of bloody diarrhoea. Although the aetiology of the disease is unknown, recent reports have implicated a cytotoxin, verotoxin, in the pathogenesis of this disorder.2 Verotoxin is present in culture filtrates of certain strains of Escherichia coli and can induce cytopathic changes in vero cells. These strains have been isolated from faeces,2 while several neuraminidase producing organisms3 have been isolated from blood of patients with the haemolytic uraemic syndrome. Explanations as to the pathogenesis of the platelet microthrombi and deposited fibrin in the haemolytic uraemic syndrome includes platelet endothelial cell interaction,4 with possible primary endothelial cell damage,5 or the presence of a platelet aggregating agent as reported in some cases of thrombotic 6 thrombocytopenic purpura.
We report here the effect of culture filtrates from verotoxin producing E coli strains and Clostridium perfringens (a neuraminidase producing organism) on plasma and platelets.
Material and methods
Venous blood was collected from three normal adults, one patient with severe classical von Willebrand's disease, and three patients with inherited Accepted for publication 19 December 1984 platelet defects (one with Bernard-Soulier syndrome and two with thrombasthenia). Nine parts of blood was added to one part of 0'11 M trisodium citrate. Platelet rich plasma (PRP) was prepared by centrifugation at 200 g for 8 min at room temperature. Platelet poor plasma (PPP) was prepared by centrifugation at 1500 g for 15 min. For platelet aggregation studies, the PRP was diluted with the subject's own PPP to give a final platelet concentration of 300 x 109/l. Fresh washed platelets were prepared using the albumin layering technivque described by Walsh ,ug/ml), sulphinpyrazole (final concentration 10 ,ug/ml), and dipyridamole (final concentration 80 ,ug/ml) before the addition of verotoxin treated plasma and subsequent platelet aggregation. Prostacyclin was added to PRP at a final concentration of 100 ,umol/l before the addition of verotoxin treated normal PPP. The effect was monitored in the aggregometer. Normal PPP, after incubation with verotoxin, was incubated for a further 90 min at room temperature with sodium heparin (final concentration 170 units/ml) before the addition of normal PRP and testing for platelet aggregation. The same quantity of heparin added to 10 units/ml of thrombin appeared to neutralise all the thrombin, as after neutralisation no thrombin induced platelet aggregation was obtained.
TESTS USING NEURAMINIDASE TREATED PPP
As platelet aggregation was noted after the addition of Cl perfringens treated plasma, the effect of incubation of normal plasma with purified neuraminidase Sigma V (final concentration 1 mg/ml) was tested. After 24 h incubation at 37°C, the neuraminidase treated plasma samples were added to fresh PRP and platelet aggregation was observed.
Results
Direct addition of the filtrates of verotoxin producing E coli, a haemolytic E coli, and Cl perfringens strains to normal PRP failed to produce platelet aggregation. No aggregation was seen on the addition of 100 ,ul of PPP to washed platelets incubated for 1 h with verotoxin.
Fresh normal plasma incubated with the verotoxin producing E coli and Cl perfringens filtrates became capable of inducing platelet aggregation (Figure) . The verotoxin producing E coli had a similar effect on the von Willebrand plasma (0% VIIIR:AG) whereas the Cl perfringens filtrate failed to change the von Willebrand plasma, suggesting a different mode of action. The action of the verotoxin producing E coli is independent of VIIIR:AG while that of Cl perfringens is dependent on the presence of VIIIR:AG. The same results as the Cl perfringens treated plasma samples could be obtained by incubating the normal and von Willebrand plasma with purified neuraminidase (Sigma V). The toxin Degree ofplatelet aggregation (expressed as % change in optical density) observed after addition of 100 yd of:
(1) normal plasma + phosphate buffered saline, pH 7-4; (2) normal plasma + culture fitrate from Clostridium perfringens; (3) normal plasma + culture fitrate from a haemolytic E coli strain; (4) normal plasma + culture fitrate from a verotoxin producing E coli to 125 p1 ofplatelet rich plasma (final concentration 300 x 0IIl). 
